Atopic Dermatitis (Eczema) Study Pre-Screener Questionnaire

We are currently recruiting subjects aged 18 to 75 years (inclusive) with moderate to severe atopic dermatitis (eczema) to participate in an investigational study. The primary purpose of this research is to figure out how safe the investigational study drug (XmAb27564) is, and how participants with atopic dermatitis (eczema) react when given the treatment multiple times. Investigational study drug means it is a drug that has not been approved by the FDA. Compensation: Compensation may be provided for time and travel. Participation will come at no cost to you. Number of visits: 23 Study length: 3 months Please respond to the following questionnaire to the best of your ability. It should take approximately 4 - 6 minutes to complete.

* Questions with a red star are mandatory.

Start Questionnaire